← Back to all trials
Not Yet Recruiting
NCT05612789
Improve Outcomes for Older Allogeneic Transplant Recipients
Conditions: Allogeneic Transplantation
Sex: All
Ages: 60 Years – N/A
Phase: NA
Enrollment: 72
Sponsor: Abramson Cancer Center of the University of Pennsylvania
Location: United States
Summary
This is an interventional pilot study to determine whether implementation of a supervised exercise program can improve outcomes in subjects undergoing allogeneic HCT.
The primary objective is to determine feasibility.
Up to 60-72 evaluable subjects will be enrolled.
Evaluable subjects are defined as those participating in the exercise intervention.
Eligibility Criteria
Inclusion Criteria:Cohort A (Prehab)Age 60 years or older.Planned allogeneic HCT in the next 1-6 months.Hematological malignancy as the indication for HCT.Pre-frail or frail by Fried frailty phenotype.Cohort B (Rehab)Age 60 years or older.Planned allogeneic HCT or HCT within the last 30 days.Hematological malignancy as the indication for HCT.Exclusion Criteria:Cohorts A and B1. Comorbid disability or illness that prevents safe exercise.
Source: ClinicalTrials.gov (NCT05612789). StuddyBuddy aggregates publicly available trial information.
